| pubmed-article:21334736 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21334736 | lifeskim:mentions | umls-concept:C1709854 | lld:lifeskim |
| pubmed-article:21334736 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:21334736 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
| pubmed-article:21334736 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:21334736 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:21334736 | pubmed:issue | 9768 | lld:pubmed |
| pubmed-article:21334736 | pubmed:dateCreated | 2011-3-7 | lld:pubmed |
| pubmed-article:21334736 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:abstractText | Non-nephrotoxic immunosuppressive strategies that allow reduction of calcineurin-inhibitor exposure without compromising safety or efficacy remain a goal in kidney transplantation. Immunosuppression based on the mammalian-target-of-rapamycin inhibitor everolimus was assessed as a strategy for elimination of calcineurin-inhibitor exposure and optimisation of renal-graft function while maintaining efficacy. | lld:pubmed |
| pubmed-article:21334736 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21334736 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21334736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21334736 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21334736 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:21334736 | pubmed:issn | 1474-547X | lld:pubmed |
| pubmed-article:21334736 | pubmed:author | pubmed-author:LidaYY | lld:pubmed |
| pubmed-article:21334736 | pubmed:author | pubmed-author:BeckerThomasT | lld:pubmed |
| pubmed-article:21334736 | pubmed:author | pubmed-author:GschaidmeierH... | lld:pubmed |
| pubmed-article:21334736 | pubmed:author | pubmed-author:FischerWolfga... | lld:pubmed |
| pubmed-article:21334736 | pubmed:author | pubmed-author:BuddeKlemensK | lld:pubmed |
| pubmed-article:21334736 | pubmed:author | pubmed-author:SommererClaud... | lld:pubmed |
| pubmed-article:21334736 | pubmed:author | pubmed-author:ReinkePetraP | lld:pubmed |
| pubmed-article:21334736 | pubmed:author | pubmed-author:KramerStefanS | lld:pubmed |
| pubmed-article:21334736 | pubmed:author | pubmed-author:ArnsWolfgangW | lld:pubmed |
| pubmed-article:21334736 | pubmed:author | pubmed-author:PietruckFrank... | lld:pubmed |
| pubmed-article:21334736 | pubmed:author | pubmed-author:EisenbergerUt... | lld:pubmed |
| pubmed-article:21334736 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:21334736 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21334736 | pubmed:day | 5 | lld:pubmed |
| pubmed-article:21334736 | pubmed:volume | 377 | lld:pubmed |
| pubmed-article:21334736 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21334736 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21334736 | pubmed:pagination | 837-47 | lld:pubmed |
| pubmed-article:21334736 | pubmed:dateRevised | 2011-6-14 | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:meshHeading | pubmed-meshheading:21334736... | lld:pubmed |
| pubmed-article:21334736 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21334736 | pubmed:articleTitle | Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. | lld:pubmed |
| pubmed-article:21334736 | pubmed:affiliation | Department of Nephrology, Charité University, Berlin, Germany. klemens.budde@charite.de | lld:pubmed |
| pubmed-article:21334736 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21334736 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:21334736 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21334736 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21334736 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21334736 | lld:pubmed |
